8-K: Urgent.ly Delisted from Nasdaq, Tender Offer Looms

Urgent.ly Inc. faces Nasdaq delisting due to non-compliance, with trading suspension set for March 18, 2026, as a tender offer from Agero, Inc. is announced.

Summary

• Urgent.ly Inc. (ULY) received notification from Nasdaq regarding non-compliance with the minimum net income requirement for continued listing under Nasdaq Listing Rule 5550(b).
• The company failed to regain compliance by the March 16, 2026 deadline.
• Trading of ULY common stock on Nasdaq will be suspended at the open of trading on March 18, 2026.
• The company expects and plans for its shares to be quoted by the OTC Markets Group, Inc. (OTC), specifically applying for the OTCQB Venture Market.
• The delisting is not expected to affect the company's business operations.
• Agero, Inc. (Parent) has entered into an Agreement and Plan of Merger to acquire all outstanding shares of Urgent.ly Inc. through a cash tender offer, which has not yet commenced.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a significantly negative event due to the Nasdaq delisting, which implies financial underperformance and reduced market access. The tender offer provides an exit but at a price determined by the acquirer, reflecting a distressed situation.

Positives

• The company intends to have its Common Stock quoted on the OTCQB Venture Market, providing an alternative trading venue post-Nasdaq delisting.
• The delisting is not expected to affect the company's business operations.
• A definitive merger agreement and cash tender offer from Agero, Inc. provides a potential structured exit for shareholders.

Negatives

• Delisting from Nasdaq due to failure to meet minimum net income requirements for continued listing.
• Trading suspension on Nasdaq is effective March 18, 2026.
• There is no assurance that trading on OTC will commence or continue at volumes or prices to facilitate efficient market activities.

Risks

• Uncertainties regarding the timing of the Offer and the Merger.
• The risk that the Offer or the Merger may not be completed in a timely manner or at all.
• Uncertainties regarding the percentage of the company's stockholders tendering their shares in the Offer.
• The possibility that competing offers or acquisition proposals for the company will be made.
• The possibility that any or all of the various conditions to the consummation of the Offer or the Merger may not be satisfied or waived, including the failure to receive any required regulatory approvals.
• The occurrence of any event, change, or other circumstance that could give rise to the termination of the Merger Agreement, including circumstances which would require the company to pay a termination fee or other expenses.
• The effect of the announcement or pendency of the transactions on the company's ability to retain and hire key personnel, maintain relationships with its customer partners, or its operating results and business generally.
• Risks related to diverting management's attention from the company's ongoing business operations.
• The risk that stockholder litigation in connection with the transactions may result in significant costs of defense, indemnification, and liability.
• The risk that the company may not meet the continued listing requirements of the applicable OTC market.

Future Outlook

The company expects and plans for its shares to be quoted on the OTC Markets Group, Inc. (OTCQB Venture Market) upon delisting from Nasdaq. The delisting is not expected to affect business operations. The acquisition by Agero, Inc. through a cash tender offer is anticipated, though the offer has not yet commenced.

Management Comments

• "The Company expects and plans for its shares of Common Stock to be quoted by the OTC Markets Group, Inc. (OTC) upon being delisted from Nasdaq and has submitted an application to have its securities traded on the OTCQB Venture Market (OTCQB) of OTC."
• "While the Company intends to have its Common Stock quoted on the OTCQB, the Companys Common Stock may temporarily trade on OTC Pink until the transfer to OTCQB is finalized."
• "The Company will continue to remain a reporting company under the Securities Exchange Act of 1934, as amended, until the consummation of the Offer... and the transition to the OTC is not expected to affect the Companys business operations."

Industry Context

StockSavvy.ai notes that delistings from major exchanges like Nasdaq often signal significant financial distress or strategic shifts for a company. The move to OTC markets typically results in reduced liquidity and investor visibility. However, the simultaneous announcement of a tender offer and merger by Agero, Inc. suggests a potential strategic acquisition, which could provide an orderly exit for shareholders, albeit at a price determined by the acquirer rather than a fully liquid market. This contrasts with many delistings where companies struggle to find a new trading venue or strategic partner.

Comparison to Industry Standards

• Delisting from Nasdaq due to financial non-compliance is a severe event, often leading to significant share price depreciation and reduced investor confidence, similar to other companies failing to meet exchange requirements.
• The transition to OTCQB is a common path for delisted companies, but liquidity and trading volumes on OTC markets are generally much lower than on Nasdaq, impacting price discovery and ease of trading for shareholders.
• The acquisition by Agero, Inc. through a cash tender offer provides a structured exit, which is often preferable to a company simply delisting without a clear future, as seen in cases where companies like [Hypothetical Company A] delisted and struggled to maintain any public trading or strategic interest.
• The offer from Agero, Inc. will likely be benchmarked against recent acquisitions in the roadside assistance or logistics technology sector, such as the acquisition of [Hypothetical Company B] by [Hypothetical Acquirer C] in [Year], where valuations were based on strategic fit and synergy potential rather than public market multiples.

Legal Proceedings

• Risk of stockholder litigation in connection with the transactions contemplated by the Merger Agreement.

Stakeholder Impact

• Shareholders: Will experience delisting from Nasdaq, potential reduced liquidity on OTC markets, and a cash tender offer for their shares.
• Employees: Risk related to the effect of the announcement on the company's ability to retain and hire key personnel.
• Customers/Partners: Risk related to the company's ability to maintain relationships with its customer partners.
• Regulatory Authorities: Nasdaq has taken action due to non-compliance. SEC will receive filings related to the tender offer.

Next Steps

• Trading of common stock on Nasdaq will be suspended on March 18, 2026.
• Nasdaq will file a Form 25 Notification of Delisting with the SEC, after which delisting will be effective in 10 days.
• The company expects its shares to be quoted by OTC Markets Group, Inc. (OTCQB Venture Market).
• Parent (Agero, Inc.) and Purchaser (Medford Hawk, Inc.) will file a Tender Offer Statement on Schedule TO with the SEC when the tender offer commences.
• The company will file a Solicitation/Recommendation Statement on Schedule 14D-9 with the SEC regarding the tender offer.
• The company will make additional disclosures relating to post-suspension trading as information becomes available.

Key Dates

Recommendation

The delisting from Nasdaq due to financial non-compliance is a strong negative signal, indicating fundamental issues. While a tender offer provides an exit, it typically occurs at a premium to the depressed market price, but below what a healthy company might command. Given the immediate delisting and the uncertainty of OTC trading, a seasoned investor would likely recommend selling to realize value from the tender offer rather than holding shares that will trade on a less liquid market with significant risks.

Keywords

Urgent.ly, ULY, Nasdaq delisting, tender offer, merger, Agero Inc., OTCQB, corporate governance, financial non-compliance, acquisition